USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly effective
Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall
Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall
This week’s Reviewer in the Spotlight, Dr. Ritesh Bhole, discusses communication in science and the value of genuine product reviews, both positive and negative
Explore our exclusive interviews and free resources to help support your cancer research, diagnostics, and therapy development
A novel machine learning method called DeepBAR could accelerate drug discovery and protein engineering
Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions
Explore topics from immunoassays and immunotherapeutics to high-sensitivity troponin assays, metabolomics, and in situ hybridization
The monthly safety report will be made public on the European Medicines Agency website
UP.SIGHT™ is certified to help laboratories worldwide overcome major cell line development hurdles and improve efficiency across workflows
The findings come from the largest study to date to look at inflammatory markers in COVID-19
Panel designed to provide surveillance of ongoing mutations of virus that causes COVID-19
Once considered a vestigial organelle, primary cilia are now believed to have an important function in the central nervous system
How blood culture diagnostics are enabling accurate pathogen identification, resistance detection, and timely therapy
With this partnership, Repositive is expanding its personalized medicine capabilities to support more biopharma customers
The heart has a ‘natural backup pacemaker’ that can kick into action if the primary way the organ generates electrical signals fails
The test helps save on much-needed testing supplies since it allows for testing for all four viruses with one swab
Simple, powerful user experience combines with reliability and scalability allowing users to focus on experimental results instead of process
The partnership will pair Personalis’ NeXT tumor profiling with Natera’s Signatera™ for treatment monitoring
Collaboration agreement to market AZOVA COVID-19 test collection kit online
SARS-CoV-2 testing is a powerful tool for curbing the COVID-19 pandemic and safely reopening schools and businesses
The license from ERS expands ZeClinics CRISPR IP portfolio and increases the validity and potency of zebrafish models for the drug discovery process
The research brings a deeper understanding about how fructose could be linked to diabetes and obesity